Cargando…

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia

We examined putative microglial activation as a function of illness course in schizophrenia. Microglial activity was quantified using [(11)C](R)-(1-[2-chrorophynyl]-N-methyl-N-[1-methylpropyl]-3 isoquinoline carboxamide ((11)C-(R)-PK11195) positron emission tomography (PET) in: (i) 10 individuals at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Biase, M A, Zalesky, A, O'keefe, G, Laskaris, L, Baune, B T, Weickert, C S, Olver, J, McGorry, P D, Amminger, G P, Nelson, B, Scott, A M, Hickie, I, Banati, R, Turkheimer, F, Yaqub, M, Everall, I P, Pantelis, C, Cropley, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611755/ https://www.ncbi.nlm.nih.gov/pubmed/28850113 http://dx.doi.org/10.1038/tp.2017.193

Ejemplares similares

O1.6. INCREASED COMPLEMENT FACTORS C3 AND C4 IN SCHIZOPHRENIA AND THE EARLY STAGES OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL SYMPTOMATOLOGY AND CORTICAL THICKNESS
por: Cropley, Vanessa, et al.
Publicado: (2018)

Predicting individual improvement in schizophrenia symptom severity at 1‐year follow‐up: Comparison of connectomic, structural, and clinical predictors
por: Kottaram, Akhil, et al.
Publicado: (2020)

Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia
por: Bousman, Chad A., et al.
Publicado: (2019)

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis
por: Bousman, C A, et al.
Publicado: (2013)

Delayed sleep onset in depressed young people
por: Glozier, Nicholas, et al.
Publicado: (2014)

Recent Meta-Analyses in the Clinical High Risk for Psychosis Population: Clinical Interpretation of Findings and Suggestions for Future Research
por: Nelson, Barnaby, et al.
Publicado: (2018)

T157. FRONTOSTRIATAL CONNECTIVITY IN TREATMENT-RESISTANT SCHIZOPHRENIA: RELATIONSHIP TO POSITIVE SYMPTOMS AND COGNITIVE FLEXIBILITY
por: Cropley, Vanessa, et al.
Publicado: (2018)

S187. EXPLORING NEURODEVELOPMENTAL AND FAMILIAL ORIGINS OF NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA
por: Cooper, Rebecca, et al.
Publicado: (2020)

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers
por: Clark, S R, et al.
Publicado: (2016)

O6.5. LINKING CORTICAL AND CONNECTIONAL PATHOLOGY IN SCHIZOPHRENIA
por: Di Biase, Maria, et al.
Publicado: (2018)

Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia
por: Mohamed Saini, Suriati, et al.
Publicado: (2023)

Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
por: Amminger, G. Paul, et al.
Publicado: (2015)

Erythrocyte glutathione levels as long-term predictor of transition to psychosis
por: Lavoie, S, et al.
Publicado: (2017)

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
por: Amminger, G P, et al.
Publicado: (2015)

The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes
por: Wells, Ruth, et al.
Publicado: (2015)

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study
por: Berger, M E, et al.
Publicado: (2017)

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Nelson, Barnaby, et al.
Publicado: (2020)

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids
por: Vijayakumar, Nandita, et al.
Publicado: (2016)

O2.3. ABNORMAL BRAIN AGING IN YOUTH WITH SUBCLINICAL PSYCHOSIS AND OBSESSIVE-COMPULSIVE SYMPTOMS
por: Cropley, Vanessa, et al.
Publicado: (2020)

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical course
por: Nelson, B., et al.
Publicado: (2018)

O10.8. A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS
por: Hartmann, Jessica A, et al.
Publicado: (2018)

Control of Neuroinflammation through Radiation-Induced Microglial Changes
por: Boyd, Alexandra, et al.
Publicado: (2021)

Early Intervention in Psychosis: Obvious, Effective, Overdue
por: McGorry, Patrick D.
Publicado: (2015)

The reality of mental health care for young people, and the urgent need for solutions
por: McGorry, Patrick D
Publicado: (2021)

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
por: Föcking, Melanie, et al.
Publicado: (2016)

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Berger, Maximus, et al.
Publicado: (2018)

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis
por: Mechelli, Andrea, et al.
Publicado: (2017)

Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia
por: Mostaid, M S, et al.
Publicado: (2017)

The need for early intervention for psychosis to persist throughout the COVID-19 pandemic and beyond
por: O’Donoghue, B., et al.
Publicado: (2020)

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
por: Cotton, S. M., et al.
Publicado: (2019)

Heschl’s gyrus duplication pattern and clinical characteristics in borderline personality disorder: A preliminary study
por: Takahashi, Tsutomu, et al.
Publicado: (2022)

Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk
por: Saini, S M, et al.
Publicado: (2017)

Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania
por: Dandash, Orwa, et al.
Publicado: (2018)

Pluripotential Risk and Clinical Staging: Theoretical Considerations and Preliminary Data From a Transdiagnostic Risk Identification Approach
por: Hartmann, Jessica A., et al.
Publicado: (2021)

Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study
por: Kim, Sung-Wan, et al.
Publicado: (2016)

Clinical classification in mental health at the cross-roads: which direction next?
por: Hickie, Ian B, et al.
Publicado: (2013)

The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease
por: Richards, Robert I., et al.
Publicado: (2016)

Online and Social Networking Interventions for the Treatment of Depression in Young People: A Systematic Review
por: Rice, Simon M, et al.
Publicado: (2014)

Predicting the diagnosis of autism spectrum disorder using gene pathway analysis
por: Skafidas, E, et al.
Publicado: (2014)

Response to Belgard et al.
por: Skafidas, E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_scr8gvgrossk3a89h07ar0q8rv